View full directory A–Z

Gene Target: F8 / F9

Hemophilia A & B

Hemophilia A & B is a genetic condition associated with variants in the F8 / F9 gene or genes. Molecular genetic testing can assist with diagnostic confirmation, familial assessment, and appropriate clinical evaluation.


Indications: Why test F8 / F9?

  • Clinical findings suggestive of Hemophilia A & B.
  • Family history of Hemophilia A & B or a known familial genetic variant.
  • Molecular confirmation following appropriate clinical assessment.
  • Genetic assessment of relatives where clinically indicated.

When should I take the test? Testing may be considered when clinical findings or family history suggest Hemophilia A & B and molecular confirmation is clinically indicated.

Do I need to fast or prepare? No fasting or special preparation is required.

Test Summary Specs

Turnaround Time 7 to 14 Business Days
Estimated Cost KES 28,000
Methodology Targeted PCR / Sanger / NGS Variant Panel
Sample Type 5 mL Peripheral Whole Blood (EDTA), Buccal Swabs, or Prenatal Samples
Clinical Use Diagnostic Confirmation, Carrier Screening, Reproductive Risk Assessment
-->